The odds of first-line treatment success in pediatric migraine may be lower in patients who have higher baseline headache frequency and medication overuse headache.
Investigators examined the characteristics of visual symptoms during migraine attacks in children and adolescents.
Migraine is highly prevalent in children and adolescents, affecting almost 10% of children between 5 and 15 years old and 30% of adolescents between 15 and 19 years old.
The illustration of headache symptoms through drawings may help clinicians distinguish between pseudotumor cerebri syndrome and migraine in pediatric patients.
Use of the International Classification of Headache Disorders 3 (ICHD-3) beta classification criteria vs ICHD-II may result in an increased percentage of pediatric patients diagnosed with migraine with typical aura.
Peripheral nerve blocks for pediatric headache treatment are associated with significant benefit and minimal risk.
Although a range of incidental findings may be observed on MRI obtained in pediatric headache, they are rarely indicative of a serious underlying condition.
Frequent onabotulinumtoxinA injections during a 5-year period provide effective analgesic benefits in pediatric patients presenting with chronic migraine.
Almost 10% of pediatric patients with migraine also experience various episodic syndromes. Physicians Amy Gelfand and Diana Lebron weigh in on what to look for to help you find the right diagnosis.
Nearly 10% of pediatric patients with migraines also experience episodic syndromes involving symptoms such as vomiting, vertigo, or gastrointestinal pain.
Symptoms associated with central sensitization are common in children and adolescents with migraine.
Attachment insecurity may amplify anxiety in children and adolescents with migraine without aura.
A nasal nerve block may be an effective pain relief method for children with migraines.
Botox treatment led to significant improvement in the intensity and frequency of migraine.
Clinical Pain Advisor Articles
- Analyzing Coverage of Nonpharmacologic Treatments for Low Back Pain
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Operant Learning May Provide More Benefits Than Energy Conservation in Fibromyalgia
- Predicting the Magnitude of Placebo Analgesia in Chronic Pain
- Dsuvia Gains FDA Approval: We Want to Hear Your Thoughts
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Cannabinoid-Associated Analgesia May Be Mediated Through Modulation of Affective Processes
- Half of the Responders to Our Poll Agree With the Approval of Dsuvia: We Want to Hear From You
- Daily Alcohol Use May Drive Chronic Pain in Adults With HIV
- Tools to Address the Opioid Crisis
- AHA/ACC Release Updated Guidelines for Cholesterol Management
- Women Fed Soy Formula as Infants More Likely to Experience Menstrual Pain